Versant Capital Management, Inc Arcturus Therapeutics Holdings Inc. Transaction History
Versant Capital Management, Inc
- $750 Million
- Q4 2025
A detailed history of Versant Capital Management, Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 265 shares of ARCT stock, worth $1,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265
Previous 61
334.43%
Holding current value
$1,926
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARCT
# of Institutions
170Shares Held
26.2MCall Options Held
2.21MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.03MShares$14.7 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...